Knowledge Hub

Vaccinating against cholera is cost-effective, especially for high-risk populations and areas with high fatality rates

A comprehensive review of the economics of cholera and cholera prevention concluded that vaccination using oral cholera vaccines can be cost-effective, especially when herd effects are taken into account and when vaccination is administered to populations and age groups with high incidence rates (e.g., children) and to areas with high cholera case fatality rates.

Full Citation:
Hsiao A, Hall AH, Mogasale V et al.. 2018. The health economics of cholera: a systematic review. Vaccine. 36(30).

Title of Article: The health economics of cholera: a systematic review

Author(s): Hsiao A, Hall AH, Mogasale V et al.

Publication Year: 2018

Publication Name: Vaccine

Publication Volume: 36(30)

Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/29907482

DOI (Digital Object Identifier): 10.1016/j.vaccine.2018.05.120

Topics: Economics & Return on Investment

Disease Vaccines: Cholera | Diarrhea

Countries: Global